IRD
NASDAQ · Biotechnology
Opus Genetics Inc
$4.11
+0.05 (+1.23%)
Open$4.05
Previous Close$4.06
Day High$4.17
Day Low$4.00
52W High$5.81
52W Low$0.90
Volume—
Avg Volume841.4K
Market Cap330.26M
P/E Ratio—
EPS$-1.32
SectorBiotechnology
Analyst Ratings
Strong Buy
20 analysts
Price Target
+464.7% upside
Current
$4.11
$4.11
Target
$23.21
$23.21
$16.63
$23.21 avg
$31.03
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 18.79M | 26.51M | 29.63M |
| Net Income | -65,640,868 | -83,335,845 | -1,185,756 |
| Profit Margin | -349.3% | -331.9% | -4.0% |
| EBITDA | -51,021,979 | -68,374,777 | -1,569,658 |
| Free Cash Flow | — | — | -1,455,645 |
| Rev Growth | -29.1% | -29.1% | +20.7% |
| Debt/Equity | 0.07 | 0.07 | 0.75 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |